GAPSS: the Global Anti-Phospholipid Syndrome Score
Savino Sciascia(Ospedale San Giovanni Bosco), María Laura Bertolaccini(St Thomas' Hospital)
Cited by 310
Related Papers
Rivaroxaban versus warfarin to treat patients with thrombotic antiphospholipid syndrome, with or without systemic lupus erythematosus (RAPS): a randomised, controlled, open-label, phase 2/3, non-inferiority trial
|The Lancet Haematology|2016|404
HYdroxychloroquine to Improve Pregnancy Outcome in Women with AnTIphospholipid Antibodies (HYPATIA) Protocol: A Multinational Randomized Controlled Trial of Hydroxychloroquine versus Placebo in Addition to Standard Treatment in Pregnant Women with Antiphospholipid Syndrome or Antibodies
|Seminars in Thrombosis and Hemostasis|2017|125
Rivaroxaban use in patients with antiphospholipid syndrome and previous venous thromboembolism
|Blood Coagulation & Fibrinolysis|2015|53
Undiagnosed diseases: Needs and opportunities in 20 countries participating in the Undiagnosed Diseases Network International
|Frontiers in Public Health|2023|23